The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A potent analog of 1α,25-dihydroxyvitamin D 3 selectively induces bone formation
Open accessAbstract
1,25-Dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] is a principal regulator of calcium and phosphorus homeostasis through actions on intestine, kidney, and bone. 1,25(OH) 2 D 3 is not considered to play a significant role in bone formation, except for its role in supporting mineralization. We report here on the properties of 2-methylene-19-nor - (20S)-1α,25(OH) 2 D 3 (2MD), a highly potent analog of 1,25(OH) 2 D 3 that induces bone formation both in vitro and in vivo . Selectivity for bone was first demonstrated through the observation that 2MD is at least 30-fold more effective than 1,25(OH) 2 D 3 in stimulating osteoblast-mediated bone calcium mobilization while being only slightly more potent in supporting intestinal calcium transport. 2MD is also highly potent in promoting osteoblast-mediated osteoclast formation in vitro , a process essential to both bone resorption and formation. Most significantly, 2MD at concentrations as low as 10 −12 M causes primary cultures of osteoblasts to produce bone in vitro . This effect is not found with 1,25(OH) 2 D 3 even at 10 −8 M, suggesting that 2MD might be osteogenic in vivo . Indeed, 2MD (7 pmol/day) causes a substantial increase (9%) in total body bone mass in ovariectomized rats over a 23-week period. 1,25(OH) 2 D 3 (500 pmol three times a week) only prevented the bone loss associated with ovariectomy and did not increase bone mass. These results indicate that 2MD is a potent bone-selective analog of 1,25(OH) 2 D 3 potentially effective in treating bone loss diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Morony, S., Capparelli, C., Lee, R., Shimamoto, G., Boone, T., Lacey, D. L., & Dunstan, C. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1478 · Cited by 187
Cited by
Overview of general physiologic features and functions of vitamin D
DeLuca, H. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1689s · Cited by 2,327
Self-citationVitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
Noncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Vitamin D, disease and therapeutic opportunities
Plum, L. A., & DeLuca, H. F. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3318 · Cited by 477
Self-citationNew insights into the mechanisms of vitamin D action
Christakos, S., Dhawan, P., Liu, Y., Peng, X., & Porta, A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10423 · Cited by 324
Metadata
- Authors
- Shevde, N. K., Plum, L. A., Clagett-Dame, M., Yamamoto, H., Pike, J. W., & DeLuca, H. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-08
- Volume
- 99
- Issue
- 21
- Pages
- 13487-13491
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2056116219
- Cited by
- 176
- References
- 2
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A potent analog of 1α,25-dihydroxyvitamin D 3 selectively induces bone formation. https://app.cochat.ai/papers/10.1073/pnas.202471299
- The paper
- Shevde, N. K., Plum, L. A., Clagett-Dame, M., Yamamoto, H., Pike, J. W., & DeLuca, H. F. (2002). A potent analog of 1α,25-dihydroxyvitamin D 3 selectively induces bone formation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.202471299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.